Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion

被引:86
作者
Marais, E
Genade, S
Huisamen, B
Strijdom, JG
Moolman, JA
Lochner, A
机构
[1] Univ Stellenbosch, Fac Med, Dept Med Physiol & Biochem, ZA-7505 Tygerberg, South Africa
[2] MRC, Expt Biol Programme, Tygerberg, South Africa
关键词
preconditioning; p38; MAPK; isolated perfused heart; ischaemia; reperfusion;
D O I
10.1006/jmcc.2001.1347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of p38 mitogen-activated protein kinase (MAPK) in ischaemic preconditioning remains controversial, Since most previous studies focussed on events only during sustained ischaemia, the aim of this study was to establish the activation pattern of p38 MAPK during a multicycle preconditioning protocol, sustained ischaemia as well as reperfusion and to correlate these events with functional recovery of the isolated perfused rat heart. Isolated perfused rat hearts were preconditioned by 3 x 5 min global ischaemia followed by 25 min global ischaemia and 30 min reperfusion. Non-preconditioned hearts were subjected to 25 min global ischaemia and 30 min reperfusion, Hearts were freeze-clamped and p38 MAPK activation in tissue lysates was assessed 631 standard Western blotting techniques using a dual phospho-p38 MAPK antibody as well as a non-radioactive IP-kinase assay. The results showed that transient dual phosphorylation and activation of p38 R MAPK occurs during a 3 x 5 min preconditioning protocol: the activation was maximal during the first episode, becoming progressively lower during the second and third episodes, p38 MAPK activation was significantly less during both sustained ischaemia and reperfusion in preconditioned hearts, when compared with non-preconditioned hearts. Attenuation of p38 MAPK activity during sustained ischaemia and reperfusion was associated with improved functional recovery. The effect of inhibition of p38 MAPK activation on cardioprotection was further evaluated in adult, isolated cardiomyocytes. Administration of SE 203580 (1-10 muM) before and during the preconditioning protocol, had no effect on cell morphology and viability after 2 h hypoxia, compared to untreated preconditioned cardiomyocytes. When administered to non-preconditioned cells before the onset of 2 h hypoxia, it caused a significant improvement in both morphology and viability. In summary, the results suggest that attenuation of the kinase activity during sustained ischaemia and reperfusion may be an essential element of the preconditioning process. (C) 2001 Academic Press.
引用
收藏
页码:769 / 778
页数:10
相关论文
共 36 条
[11]   THE CELL BIOLOGY OF ACUTE MYOCARDIAL-ISCHEMIA [J].
JENNINGS, RB ;
REIMER, KA .
ANNUAL REVIEW OF MEDICINE, 1991, 42 :225-246
[12]   IMPAIRED CARDIAC WORK AND OXYGEN-UPTAKE AFTER REPERFUSION OF REGIONALLY ISCHEMIC MYOCARDIUM [J].
KANNENGIESSER, GJ ;
OPIE, LH ;
VANDERWERFF, TJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1979, 11 (02) :197-207
[13]   Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells [J].
Kawasaki, H ;
Morooka, T ;
Shimohama, S ;
Kimura, J ;
Hirano, T ;
Gotoh, Y ;
Nishida, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18518-18521
[14]   Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart [J].
Knight, RJ ;
Buxton, DB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (01) :83-88
[15]   Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase [J].
Kummer, JL ;
Rao, PK ;
Heidenreich, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20490-20494
[16]   Nitric oxide: a trigger for classic preconditioning? [J].
Lochner, A ;
Marais, E ;
Genade, S ;
Moolman, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (06) :H2752-H2765
[17]   Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion [J].
Ma, XL ;
Kumar, S ;
Gao, F ;
Louden, CS ;
Lopez, BL ;
Christopher, TA ;
Wang, CL ;
Lee, JC ;
Feuerstein, GZ ;
Yue, TL .
CIRCULATION, 1999, 99 (13) :1685-1691
[18]   Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia [J].
Mackay, K ;
Mochly-Rosen, D .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (08) :1585-1588
[19]   An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia [J].
Mackay, K ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6272-6279
[20]   Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2 [J].
Maulik, N ;
Yoshida, T ;
Zu, YL ;
Sato, M ;
Banerjee, A ;
Das, DK .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05) :H1857-H1864